These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 32508634)

  • 1. New Pharmacological Strategies for the Treatment of Non-Infectious Uveitis. A Minireview.
    Valenzuela RA; Flores I; Urrutia B; Fuentes F; Sabat PE; Llanos C; Cuitino L; Urzua CA
    Front Pharmacol; 2020; 11():655. PubMed ID: 32508634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on non-infectious uveitis treatment: anti-TNF-alpha and beyond.
    Chauhan K; Tyagi M
    Front Ophthalmol (Lausanne); 2024; 4():1412930. PubMed ID: 39157460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis and current therapies for non-infectious uveitis.
    Wu X; Tao M; Zhu L; Zhang T; Zhang M
    Clin Exp Med; 2023 Aug; 23(4):1089-1106. PubMed ID: 36422739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of immunomodulators in non-infectious uveitis: lights and shadows.
    Bernal-Morales C; Ramanan AV; Pavesio C
    Eye (Lond); 2024 Dec; 38(17):3231-3242. PubMed ID: 39160332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunosuppressive therapy in severe or chronic pediatric uveitis: Review of the literature].
    Stolowy N; Zanin E; Comet A; Jurquet AL; Benso C; Matonti F; Retornaz K; Kaplanski G; Denis D
    J Fr Ophtalmol; 2021 Feb; 44(2):252-258. PubMed ID: 33423814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotherapies in Uveitis.
    Leclercq M; Desbois AC; Domont F; Maalouf G; Touhami S; Cacoub P; Bodaghi B; Saadoun D
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33171664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New observations and emerging ideas in diagnosis and management of non-infectious uveitis: A review.
    Rosenbaum JT; Bodaghi B; Couto C; Zierhut M; Acharya N; Pavesio C; Tay-Kearney ML; Neri P; Douglas K; Pathai S; Song AP; Kron M; Foster CS
    Semin Arthritis Rheum; 2019 Dec; 49(3):438-445. PubMed ID: 31301816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of biologic agents in the management of uveitis.
    Trivedi A; Katelaris C
    Intern Med J; 2019 Nov; 49(11):1352-1363. PubMed ID: 30582273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients.
    Riancho-Zarrabeitia L; Calvo-Río V; Blanco R; Mesquida M; Adan AM; Herreras JM; Aparicio Á; Peiteado-Lopez D; Cordero-Coma M; García Serrano JL; Ortego-Centeno N; Maíz O; Blanco A; Sánchez-Bursón J; González-Suárez S; Fonollosa A; Santos-Gómez M; González-Vela C; Loricera J; Pina T; González-Gay MA
    Semin Arthritis Rheum; 2015 Dec; 45(3):361-8. PubMed ID: 26092330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges for further successful development of tumor necrosis factor targeting therapies for uveitis.
    Thng ZX; Regenold J; Bromeo AJ; Akhavanrezayat A; Than NTT; Khatri A; Mohammadi SS; Tran ANT; Shin YU; Karaca I; Ghoraba HH; Or CCM; Nguyen QD
    Expert Opin Investig Drugs; 2024 Feb; 33(2):95-104. PubMed ID: 38299551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of intravitreal anti-tumour necrosis factor drugs in adults with non-infectious uveitis - a systematic review.
    Leal I; Rodrigues FB; Sousa DC; Romão VC; Duarte GS; Carreño E; Dick AD; Marques-Neves C; Costa J; Fonseca JE
    Acta Ophthalmol; 2018 Sep; 96(6):e665-e675. PubMed ID: 29577629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging drugs for uveitis.
    Larson T; Nussenblatt RB; Sen HN
    Expert Opin Emerg Drugs; 2011 Jun; 16(2):309-22. PubMed ID: 21210752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first investigation on differences in the effectiveness of mycophenolate mofetil and azathioprine antimetabolites determined in Polish patients treated for non-infectious uveitis.
    Waszczyk-Łączak M; Łazicka-Gałecka M; Chomicz L; Mucha K; Pączek L; Szaflik JP
    Ann Agric Environ Med; 2020 Dec; 27(4):644-649. PubMed ID: 33356073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics.
    Thomas AS
    Curr Opin Ophthalmol; 2019 May; 30(3):138-150. PubMed ID: 30844945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive therapy for eye diseases: Effectiveness, safety, side effects and their prevention.
    Hornbeak DM; Thorne JE
    Taiwan J Ophthalmol; 2015; 5(4):156-163. PubMed ID: 29018691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the use of systemic biologic agents in the treatment of noninfectious uveitis.
    Pasadhika S; Rosenbaum JT
    Biologics; 2014; 8():67-81. PubMed ID: 24600203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Knowledge of Biologics in Treatment of Noninfectious Uveitis.
    Gupta S; Shyamsundar K; Agrawal M; Vichare N; Biswas J
    J Ocul Pharmacol Ther; 2022 Apr; 38(3):203-222. PubMed ID: 35133890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New therapies in development for the management of non-infectious uveitis: A review.
    Hassan M; Karkhur S; Bae JH; Halim MS; Ormaechea MS; Onghanseng N; Nguyen NV; Afridi R; Sepah YJ; Do DV; Nguyen QD
    Clin Exp Ophthalmol; 2019 Apr; 47(3):396-417. PubMed ID: 30938012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expert opinion on the use of biological therapy in non-infectious uveitis.
    Touhami S; Diwo E; Sève P; Trad S; Bielefeld P; Sène D; Abad S; Brézin A; Quartier P; Koné Paut I; Weber M; Chiquet C; Errera MH; Sellam J; Cacoub P; Kaplanski G; Kodjikian L; Bodaghi B; Saadoun D
    Expert Opin Biol Ther; 2019 May; 19(5):477-490. PubMed ID: 30888881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges.
    Massa H; Pipis SY; Adewoyin T; Vergados A; Patra S; Panos GD
    Clin Ophthalmol; 2019; 13():1761-1777. PubMed ID: 31571815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.